139 related articles for article (PubMed ID: 34381917)
1. The effect of cardiac geometry variation according to sex and race on outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Ha ET; Cohen M; Gaeta TJ; Parikh MA; Peterson SJ; Aronow WS
Arch Med Sci Atheroscler Dis; 2021; 6():e152-e159. PubMed ID: 34381917
[TBL] [Abstract][Full Text] [Related]
2. Eccentric hypertrophy predicts adverse events in patients undergoing percutaneous coronary intervention for acute coronary syndrome.
Ha ET; Cohen M; Peterson SJ; Aronow WS
Arch Med Sci Atheroscler Dis; 2021; 6():e21-e27. PubMed ID: 34027210
[TBL] [Abstract][Full Text] [Related]
3. Sex-related differences in outcomes among men and women under 55 years of age with acute coronary syndrome undergoing percutaneous coronary intervention: Results from the PROMETHEUS study.
Chandrasekhar J; Baber U; Sartori S; Faggioni M; Aquino M; Kini A; Weintraub W; Rao S; Kapadia S; Weiss S; Strauss C; Toma C; Muhlestein B; DeFranco A; Effron M; Keller S; Baker B; Pocock S; Henry T; Mehran R
Catheter Cardiovasc Interv; 2017 Mar; 89(4):629-637. PubMed ID: 27152497
[TBL] [Abstract][Full Text] [Related]
4. Effects of upstream tirofiban versus downstream tirofiban on myocardial damage and 180-day clinical outcomes in high-risk acute coronary syndromes patients undergoing percutaneous coronary interventions.
Liu T; Xie Y; Zhou YJ; Li YP; Ma HY; Guo YH; Liu YY; Zhao YX; Shi DM
Chin Med J (Engl); 2009 Aug; 122(15):1732-7. PubMed ID: 19781316
[TBL] [Abstract][Full Text] [Related]
5. Sex-based differences in outcomes after percutaneous coronary intervention for acute myocardial infarction: a report from TRANSLATE-ACS.
Hess CN; McCoy LA; Duggirala HJ; Tavris DR; O'Callaghan K; Douglas PS; Peterson ED; Wang TY
J Am Heart Assoc; 2014 Feb; 3(1):e000523. PubMed ID: 24510115
[TBL] [Abstract][Full Text] [Related]
6. Association of Ticagrelor vs Clopidogrel With Major Adverse Coronary Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
Turgeon RD; Koshman SL; Youngson E; Har B; Wilton SB; James MT; Graham MM
JAMA Intern Med; 2020 Mar; 180(3):420-428. PubMed ID: 31930361
[TBL] [Abstract][Full Text] [Related]
7. Neurotensin and Adverse Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention.
Tscharre M; Farhan S; Freynhofer MK; Leutner M; Baumgartner-Parzer S; Tentzeris I; Vogel B; Tinhofer F; Rohla M; Weiss TW; Huber K; Kautzky-Willer A
Front Cardiovasc Med; 2022; 9():782602. PubMed ID: 35345492
[TBL] [Abstract][Full Text] [Related]
8. Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS Study.
Baber U; Chandrasekhar J; Sartori S; Aquino M; Kini AS; Kapadia S; Weintraub W; Muhlestein JB; Vogel B; Faggioni M; Farhan S; Weiss S; Strauss C; Toma C; DeFranco A; Baker BA; Keller S; Effron MB; Henry TD; Rao S; Pocock S; Dangas G; Mehran R
JACC Cardiovasc Interv; 2017 Oct; 10(20):2017-2025. PubMed ID: 28780028
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions].
Zhang DP; Wang LF; Liu Y; Li KB; Xu L; Li WM; Ni ZH; Xia K; Zhang ZY; Yang XC
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):600-607. PubMed ID: 32842271
[No Abstract] [Full Text] [Related]
10. Effect of sex difference in clinical presentation (stable coronary artery disease vs unstable angina pectoris or non-ST-elevation myocardial infarction vs ST-elevation myocardial infarction) on 2-year outcomes in patients undergoing percutaneous coronary intervention.
Tang XF; Song Y; Xu JJ; Ma YL; Zhang JH; Yao Y; He C; Wang HH; Jiang P; Jiang L; Liu R; Gao Z; Zhao XY; Qiao SB; Xu B; Yang YJ; Gao RL; Yuan JQ
J Interv Cardiol; 2018 Feb; 31(1):5-14. PubMed ID: 29023996
[TBL] [Abstract][Full Text] [Related]
11. [Prognosis after acute coronary syndrome. Lack of difference according to the sex].
Bounhoure JP; Farah B; Fajadet J; Marco J
Bull Acad Natl Med; 2004; 188(3):383-97; discussion 397-9. PubMed ID: 15584651
[TBL] [Abstract][Full Text] [Related]
12. Impact of sex on long-term cardiovascular outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes.
Roumeliotis A; Claessen BE; Sartori S; Cao D; Qiu H; Camaj A; Nicolas J; Chandiramani R; Goel R; Chiarito M; Torguson R; Sweeny J; Barman N; Krishnan P; Kini A; Sharma SK; Dangas G; Mehran R
Catheter Cardiovasc Interv; 2021 Oct; 98(4):E494-E500. PubMed ID: 34032363
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of the Residual SYNTAX Score After Functionally Complete Revascularization in ACS.
Kobayashi Y; Lønborg J; Jong A; Nishi T; De Bruyne B; Høfsten DE; Kelbæk H; Layland J; Nam CW; Pijls NHJ; Tonino PAL; Warnøe J; Oldroyd KG; Berry C; Engstrøm T; Fearon WF;
J Am Coll Cardiol; 2018 Sep; 72(12):1321-1329. PubMed ID: 30213322
[TBL] [Abstract][Full Text] [Related]
14. Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial.
Stone GW; Généreux P; Harrington RA; White HD; Gibson CM; Steg PG; Hamm CW; Mahaffey KW; Price MJ; Prats J; Deliargyris EN; Bhatt DL
Eur Heart J; 2018 Dec; 39(46):4112-4121. PubMed ID: 30203006
[TBL] [Abstract][Full Text] [Related]
15. Prasugrel (Efient®) with percutaneous coronary intervention for treating acute coronary syndromes (review of TA182): systematic review and economic analysis.
Greenhalgh J; Bagust A; Boland A; Dwan K; Beale S; Fleeman N; McEntee J; Dundar Y; Richardson M; Fisher M
Health Technol Assess; 2015 Apr; 19(29):1-130. PubMed ID: 25896573
[TBL] [Abstract][Full Text] [Related]
16. The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry.
Ge Z; Baber U; Claessen BE; Farhan S; Chandrasekhar J; Li SX; Sartori S; Kini AS; Rao SV; Weiss S; Henry TD; Vogel B; Sorrentino S; Faggioni M; Kapadia S; Muhlestein B; Strauss C; Toma C; DeFranco A; Effron MB; Keller S; Baker BA; Pocock S; Dangas G; Mehran R
Catheter Cardiovasc Interv; 2019 Feb; 93(3):E112-E119. PubMed ID: 30351514
[TBL] [Abstract][Full Text] [Related]
17. Coronary Artery Bypass Surgery Compared With Percutaneous Coronary Intervention for Proximal Left Anterior Descending Artery Treatment in Patients With Acute Coronary Syndrome: Analysis From the ACUITY Trial.
Mennuni MG; Dangas GD; Mehran R; Ben-Gal Y; Xu K; Généreux P; Brener SJ; Feit F; Lincoff AM; Ohman EM; Hamon M; Stone GW
J Invasive Cardiol; 2015 Oct; 27(10):468-73. PubMed ID: 26121708
[TBL] [Abstract][Full Text] [Related]
18. [Medication compliance for secondary prevention and long-term outcome among patients with acute coronary syndrome after percutaneous coronary intervention in different regions].
Wang X; Li Y; Li J; Qiu MH; Qi ZZ; Li XY; Li YZ; Na K; Han YL
Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Feb; 49(2):143-149. PubMed ID: 33611900
[No Abstract] [Full Text] [Related]
19. Cardiovascular Risk Profile, Presentation and Management Outcomes of Patients with Acute Coronary Syndromes after Coronary Artery Bypass Grafting.
Mahmoud SES; Shahin M; Yousif N; Denegri A; Abo Dahab LH; Lüscher TF
Curr Probl Cardiol; 2022 Nov; 47(11):101078. PubMed ID: 34902394
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of the index of microcirculatory resistance after percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome.
Murai T; Yonetsu T; Kanaji Y; Usui E; Hoshino M; Hada M; Hamaya R; Kanno Y; Lee T; Kakuta T
Catheter Cardiovasc Interv; 2018 Nov; 92(6):1063-1074. PubMed ID: 29446567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
